1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

Jervell Lange-Nielsen syndrome

  1. Molecular mechanisms underlying the long QT syndrome.
  2. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.
  3. Long QT syndrome: ionic basis and arrhythmia mechanism in long QT syndrome type 1.
  4. [Long QT--a polymorphic syndrome].
  5. Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen.
  6. Cochlear implantation in Jervell and Lange-Nielsen syndrome.
  7. KCNQ1/KCNE1 potassium channels in mammalian vestibular dark cells.
  8. [Possibility of gene-specific treatment for hereditary arrhythmic diseases].
  9. A spectrum of functional effects for disease causing mutations in the Jervell and Lange-Nielsen syndrome.
  10. A new spontaneous mouse mutation in the Kcne1 gene.
  11. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice.
  12. Evaluation and treatment of pediatric patients with congenital or acquired long QT interval syndromes.
  13. Molecular biology and the prolonged QT syndromes.
  14. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome.
  15. The long QT syndromes: genetic basis and clinical implications.
  16. GeneReviews™
  17. The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene.
  18. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
  19. [Homozygotous mutation of the SCN5A gene responsible for congenital long QT syndrome with 2/1 atrioventricular block].
  20. Preliminary cardiological examinations in deaf children.